Rankings
▼
Calendar
FOLD Q1 2025 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$125M
+13.4% YoY
Gross Profit
$114M
90.7% margin
Operating Income
-$8M
-6.3% margin
Net Income
-$22M
-17.3% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
-16.3%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$8M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$790M
Total Liabilities
$596M
Stockholders' Equity
$194M
Cash & Equivalents
$182M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$125M
$110M
+13.4%
Gross Profit
$114M
$97M
+17.3%
Operating Income
-$8M
-$28M
+71.3%
Net Income
-$22M
-$48M
+55.2%
Geographic Segments
Non-US
$64M
61%
UNITED STATES
$40M
39%
← FY 2025
All Quarters
Q2 2025 →